| Date | Title | Description |
| 19.09.2024 | BioStock: Saniona comments on the approval to initiate epilepsy study | BioStock: Saniona comments on the approval to initiate epilepsy study
Thu, Sep 19, 2024 10:37 CET Report this content
Saniona has received approval to initiate a phase I multiple ascending dose and biomarker study in adults for SAN711, mark... |
| 19.09.2024 | The most shorted life science stocks in the Nordic region | The most shorted life science stocks in the Nordic region
Thu, Sep 19, 2024 08:15 CET Report this content
US interest rate cuts are drawing ever closer and are expected to ease the pressure on a hard-pressed life science sector. However, no... |
| 18.09.2024 | BioStock: Abliva leads the fight against mitochondrial disease | BioStock: Abliva leads the fight against mitochondrial disease
Wed, Sep 18, 2024 09:38 CET Report this content
This week, mitochondrial disease is in focus during Mitochondrial Disease Week, highlighting a condition that, despite its often ... |
| 17.09.2024 | BioStock: Medivir – live from ESMO in Barcelona | BioStock: Medivir – live from ESMO in Barcelona
Tue, Sep 17, 2024 15:45 CET Report this content
At the ESMO conference in Barcelona, Medivir presented mature results from its ongoing Phase Ib/IIa trial of fostrox in combination with Lenvima... |
| 17.09.2024 | Interviews with key players at Investing in Life Science | Interviews with key players at Investing in Life Science
Tue, Sep 17, 2024 15:37 CET Report this content
When BioStock, in collaboration with Vator Securities, organized the “Investing in Life Science: From Seed to Success” event, investors... |
| 16.09.2024 | BioStock: The future of obesity treatment - Iconovo develops intranasal semaglutide | BioStock: The future of obesity treatment - Iconovo develops intranasal semaglutide
Mon, Sep 16, 2024 08:54 CET Report this content
Iconovo has initiated the development of an intranasally inhaled and reformulated version of semaglutide to ... |
| 16.09.2024 | Investing in life science: From Seed to Success 2024 | Investing in life science: From Seed to Success 2024
Mon, Sep 16, 2024 11:35 CET Report this content
Last week, investors and entrepreneurs gathered at the World Trade Center in Stockholm for our “Investing in Life Science: From Seed to Suc... |
| 16.09.2024 | BioStock: BioInvent’s CMO comments on the ESMO presentation | BioStock: BioInvent’s CMO comments on the ESMO presentation
Mon, Sep 16, 2024 12:59 CET Report this content
BioInvent and Transgene presented promising phase I/IIa data on BT-001 at ESMO in Barcelona this weekend. BioStock contacted BioInve... |
| 13.09.2024 | BioStock: AdjuTec Pharma to start phase I trial with APC148 | BioStock: AdjuTec Pharma to start phase I trial with APC148
Fri, Sep 13, 2024 08:15 CET Report this content
Adjutec is set to start its phase I clinical trial for the enzyme inhibitor APC148, marking a significant milestone for the company.... |
| 13.09.2024 | BioStock: BioInvent makes a strong entrance at ESMO in Barcelona | BioStock: BioInvent makes a strong entrance at ESMO in Barcelona
Fri, Sep 13, 2024 11:19 CET Report this content
BioInvent has released additional positive preliminary efficacy data from its ongoing phase IIa dose expansion study of BI-1808... |
| 12.09.2024 | BioStock: Final study results - ColdZyme reduces illness duration and alleviates symptoms | BioStock: Final study results - ColdZyme reduces illness duration and alleviates symptoms
Thu, Sep 12, 2024 11:09 CET Report this content
An independent investigator-initiated study from the University of Kent demonstrates that Enzymatica’s... |
| 11.09.2024 | BioStock: Lipum and NorthX Biologics – a deep dive into the collaboration and production process | BioStock: Lipum and NorthX Biologics – a deep dive into the collaboration and production process
Wed, Sep 11, 2024 08:56 CET Report this content
Lipum has initiated the manufacturing process of SOL-116 for phase II studies in collaboration ... |
| 10.09.2024 | BioStock: Curasight carries out the first step of capitalization | BioStock: Curasight carries out the first step of capitalization
Tue, Sep 10, 2024 08:15 CET Report this content
In late June, Curasight announced a capital raise package of up to DKK 120 million to finance the ongoing development of its th... |
| 10.09.2024 | ExpreS2ion to present in upcoming investor events | ExpreS2ion to present in upcoming investor events
Tue, Sep 10, 2024 14:00 CET Report this content
Hørsholm, Denmark, 10 September 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will parti... |
| 09.09.2024 | BioStock has published an article on the approved OMPD for CS1 in the EU including an interview of Cereno Scientific’s CEO Sten R. Sörensen | BioStock has published an article on the approved OMPD for CS1 in the EU including an interview of Cereno Scientific’s CEO Sten R. Sörensen
Mon, Sep 09, 2024 14:13 CET Report this content
Cereno Scientific (Nasdaq First North: CRNO B), a pi... |
| 09.09.2024 | BioStock: Cereno comments on EU orphan designation for CS1 | BioStock: Cereno comments on EU orphan designation for CS1
Mon, Sep 09, 2024 13:27 CET Report this content
Cereno Scientific has received Orphan Medicinal Product Designation in the EU for CS1 in Pulmonary Arterial Hypertension, a rare card... |
| 06.09.2024 | BioStock: Promising results in Chordate’s follow-up study | BioStock: Promising results in Chordate’s follow-up study
Fri, Sep 06, 2024 10:59 CET Report this content
Chordate Medical has conducted an initial data analysis in the long-term study PM010 with its migraine treatment Ozilia. According to ... |
| 06.09.2024 | BioStock: Biosergen’s CEO: “The first patient regained his health” | BioStock: Biosergen’s CEO: “The first patient regained his health”
Fri, Sep 06, 2024 12:35 CET Report this content
In Biosergen’s Q2 report, the company highlights the successful start of the phase Ib study with BSG005. The first patient wi... |
| 06.09.2024 | BiBB’s CEO to BioStock: “Zagreb confirms good samples and short learning curve” | BiBB’s CEO to BioStock: “Zagreb confirms good samples and short learning curve”
Fri, Sep 06, 2024 08:15 CET Report this content
The clinical introduction is in full swing for BiBBInstruments. The company’s first electric-driven biopsy instr... |
| 05.09.2024 | BioStock: Spago Nanomedical strengthened management to reflect project progress | BioStock: Spago Nanomedical strengthened management to reflect project progress
Thu, Sep 05, 2024 14:17 CET Report this content
The clinical phase I/IIa study evaluating radiopharmaceutical candidate 177Lu-SN201 in solid tumours has been pr... |
| 03.09.2024 | BioStock: Focus on market establisment for Chordate | BioStock: Focus on market establisment for Chordate
Tue, Sep 03, 2024 11:23 CET Report this content
As Chordate Medical reports its second-quarter results, it is no surprise that the spotlight is on the recently signed agreement with Neurol... |
| 03.09.2024 | BioStock: Alligator brings in new CFO ahead of phase III | BioStock: Alligator brings in new CFO ahead of phase III
Tue, Sep 03, 2024 09:09 CET Report this content
As Alligator Bioscience approaches phase III with its lead cancer immunotherapy candidate mitazalimab, increasing its business developm... |
| 03.09.2024 | Elicera Therapeutics will participate in upcoming industry and investor conferences during the fall | Elicera Therapeutics will participate in upcoming industry and investor conferences during the fall
Tue, Sep 03, 2024 08:45 CET Report this content
Gothenburg, September 3, 2024 – Elicera Therapeutics AB (publ), a clinical stage cell and ge... |
| 02.09.2024 | BioStock: Prolight Diagnostics advances towards validation of test for myocardial infarction diagnostics | BioStock: Prolight Diagnostics advances towards validation of test for myocardial infarction diagnostics
Mon, Sep 02, 2024 08:52 CET Report this content
Prolight Diagnostics’ report for the second quarter marks significant progress in devel... |
| 02.09.2024 | BioStock: Saniona aiming for new clinical data and first market approval | BioStock: Saniona aiming for new clinical data and first market approval
Mon, Sep 02, 2024 14:42 CET Report this content
In its recently published interim report, Saniona’s CEO Thomas Feldthus highlights the external interest in one of the ... |
| 02.09.2024 | BioStock: BioInvent anticipates a continued data-rich 2024 | BioStock: BioInvent anticipates a continued data-rich 2024
Mon, Sep 02, 2024 08:54 CET Report this content
With cash reserves surpassing one billion SEK, providing significant operational flexibility, and anticipating results from several o... |
| 29.08.2024 | Cereno Scientific releases BioStock interview with CEO Sten R. Sörensen regarding the Q2 Report 2024 | Cereno Scientific releases BioStock interview with CEO Sten R. Sörensen regarding the Q2 Report 2024
Thu, Aug 29, 2024 14:07 CET Report this content
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative ... |
| 29.08.2024 | BioStock: Cereno's CEO – "very excited for topline readout!" | BioStock: Cereno's CEO – "very excited for topline readout!"
Thu, Aug 29, 2024 13:55 CET Report this content
Cereno Scientific has released its Q2 report for 2024, highlighting the company's advancements in developing cardiovascul... |
| 29.08.2024 | BioStock: Curasight targets clinical proof-of-concept for uTREAT | BioStock: Curasight targets clinical proof-of-concept for uTREAT
Thu, Aug 29, 2024 08:15 CET Report this content
Having secured financing for the ongoing clinical development of uTRACE, Curasight can now enter the next level in developing t... |
| 28.08.2024 | The Race for Innovation: CombiGene and Lipum Forge Ahead | In the world of biotechnology, the race for innovation is relentless. Companies like CombiGene and Lipum are sprinting toward new horizons, driven by ambition and the promise of breakthroughs. Their recent moves highlight a landscape rich w... |
| 28.08.2024 | Medivir and Lipum: Pioneering Paths in Cancer and Arthritis Treatments | In the ever-evolving landscape of pharmaceuticals, two companies stand out: Medivir and Lipum. Both are making strides in their respective fields—advanced liver cancer and rheumatoid arthritis. Their recent developments are not just increme... |
| 28.08.2024 | Medivir and CombiGene: Navigating the Landscape of Advanced Cancer and Epilepsy Treatments | In the world of pharmaceuticals, progress is often measured in small steps. For Medivir and CombiGene, recent developments signal a promising horizon. Both companies are making strides in their respective fields: advanced liver cancer and e... |
| 28.08.2024 | BioStock: New CFO at Neola Medical | BioStock: New CFO at Neola Medical
Wed, Aug 28, 2024 08:15 CET Report this content
Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently... |
| 27.08.2024 | WntResearch’s CEO to BioStock: “Aiming for an agreement” | WntResearch’s CEO to BioStock: “Aiming for an agreement”
Tue, Aug 27, 2024 08:23 CET Report this content
WntResearch is approaching the first readout from the expansion part of the phase II study with Foxy-5 in colon cancer. In parallel, th... |
| 27.08.2024 | BioStock: Annexin: Could ANXV replace anti-VEGFs? | BioStock: Annexin: Could ANXV replace anti-VEGFs?
Tue, Aug 27, 2024 14:53 CET Report this content
Annexin Pharmaceuticals is developing the drug candidate ANXV in the eye disease retinal vein occlusion, RVO, as well as in cancer. Recently, ... |
| 26.08.2024 | Neola’s CEO to BioStock: “We are now preparing for a clinical study in the US” | Neola’s CEO to BioStock: “We are now preparing for a clinical study in the US”
Mon, Aug 26, 2024 08:15 CET Report this content
After recently receiving a CB certificate for its medical device, intensive work is now underway at Neola Medical... |
| 26.08.2024 | BioStock: Q2 marked continued progress for Medivir in advanced liver cancer | BioStock: Q2 marked continued progress for Medivir in advanced liver cancer
Mon, Aug 26, 2024 09:50 CET Report this content
At the ESMO GI congress in June, Medivir presented greatly improved results for patients with advanced liver cancer ... |
| 26.08.2024 | BioStock: Lipum recruits new CMO – “I have been following their research for a while and am impressed” | BioStock: Lipum recruits new CMO – “I have been following their research for a while and am impressed”
Mon, Aug 26, 2024 09:29 CET Report this content
In preparation for the continued clinical development of SOL-116 in rheumatoid arthritis,... |
| 26.08.2024 | BioStock: Continued focus on new licensing deals for CombiGene | BioStock: Continued focus on new licensing deals for CombiGene
Mon, Aug 26, 2024 14:35 CET Report this content
CombiGene has published its interim report for the second quarter and substantial emphasis is on the new agreement with Spark con... |
| 26.08.2024 | BioStock: Abliva's CEO – We are the leading programme in mitochondrial disease | BioStock: Abliva's CEO – We are the leading programme in mitochondrial disease
Mon, Aug 26, 2024 08:46 CET Report this content
Abliva is developing drugs for the treatment of mitochondrial diseases, and the company posted positive interim p... |
| 21.08.2024 | BioStock: How Magle Group focus their use of DSM | BioStock: How Magle Group focus their use of DSM
Wed, Aug 21, 2024 09:30 CET Report this content
The company aims to establish itself as a leader in life-changing healthcare innovations. Watch Justin Pierce, CEO and Helena Ossmer Thedius, C... |
| 15.08.2024 | BioStock: Lipum's CEO summarizes the half-year – continued positive study data | BioStock: Lipum's CEO summarizes the half-year – continued positive study data
Thu, Aug 15, 2024 08:45 CET Report this content
Lipum's report for the first half of 2024 highlights the positive interim results from the phase I study with SOL... |
| 13.08.2024 | BioStock: Respiratorius' H1 marked by positive patent decision and secured financing | BioStock: Respiratorius' H1 marked by positive patent decision and secured financing
Tue, Aug 13, 2024 08:45 CET Report this content
Respiratorius' half-year report for 2024 highlights the positive decision from the Patent Trial and Appeal ... |
| 05.08.2024 | BioStock: Prolight Diagnostics receives positive feedback at ADLM Congress | BioStock: Prolight Diagnostics receives positive feedback at ADLM Congress
Mon, Aug 05, 2024 10:14 CET Report this content
Prolight Diagnostics recently participated at the ADLM congress in Chicago, where the company had the opportunity to ... |
| 24.07.2024 | Abliva’s CEO to BioStock: “One step closer to a marketed medicine” | Abliva’s CEO to BioStock: “One step closer to a marketed medicine”
Wed, Jul 24, 2024 11:57 CET Report this content
Abliva has reported positive interim analysis results for the potentially registrational FALCON study, assessing KL1333 in pa... |
| 19.07.2024 | BioStock: BioInvent and MSD to evaluate new metastatic melanoma treatment | BioStock: BioInvent and MSD to evaluate new metastatic melanoma treatment
Fri, Jul 19, 2024 11:00 CET Report this content
BioInvent, known for its innovative cancer immunotherapies, is expanding its partnership with MSD to test BI-1607 in c... |
| 18.07.2024 | BioStock: Biosergen on dosing the first patient with life-threatening fungal disease | BioStock: Biosergen on dosing the first patient with life-threatening fungal disease
Thu, Jul 18, 2024 11:59 CET Report this content
The first patient has been dosed in Biosergen’s clinical phase Ib trial with BSG005, intended as rescue the... |
| 11.07.2024 | BioStock: PHI aims for US listing | BioStock: PHI aims for US listing
Thu, Jul 11, 2024 08:15 CET Report this content
Swedish Medtech Phase Holographic Imaging is making significant strides in the United States, establishing itself at the forefront of the rapidly growing rege... |
| 08.07.2024 | Danish pole position among best Nordic life science stocks in H1 | Danish pole position among best Nordic life science stocks in H1
Mon, Jul 08, 2024 07:45 CET Report this content
The first six months of 2024 have passed and it is time to swap the ergonomically designed office chair for a sunbed At BioStoc... |
| 08.07.2024 | BioStock: Cereno’s CEO comments on progress with CS1 and CS014 | BioStock: Cereno’s CEO comments on progress with CS1 and CS014
Mon, Jul 08, 2024 14:45 CET Report this content
Cereno Scientific reports new advancements with two of its drug candidates. The phase II study with CS1 in pulmonary arterial hyp... |
| 05.07.2024 | BioStock: Patent approval for Respiratorius after complicated process | BioStock: Patent approval for Respiratorius after complicated process
Fri, Jul 05, 2024 10:15 CET Report this content
It has been a long and arduous process, but the long-awaited announcement is finally here. The US Patent and Trademark Off... |
| 05.07.2024 | BioStock: Lipum strengthens the board with commercial expertise | BioStock: Lipum strengthens the board with commercial expertise
Fri, Jul 05, 2024 09:30 CET Report this content
Lipum has chosen to strengthen the Board of Directors with Åsa Magnusson, who has more than 30 years of experience in the pharma... |
| 04.07.2024 | BioStock: SynAct Pharma moves forward with filing process | BioStock: SynAct Pharma moves forward with filing process
Thu, Jul 04, 2024 08:58 CET Report this content
Following previous studies in rheumatoid arthritis, SynAct Pharma knows much more about the possibilies and requirements for assessing... |
| 04.07.2024 | BioStock: Arcede Pharma heading towards liquidation | BioStock: Arcede Pharma heading towards liquidation
Thu, Jul 04, 2024 10:45 CET Report this content
This spring, Arcede Pharma has worked hard to find a financing solution for the continued work on RCD405, but has not succeeded. Consequentl... |
| 03.07.2024 | BioStock: “Unprecedented” phase II data for Alligator in pancreatic cancer | BioStock: “Unprecedented” phase II data for Alligator in pancreatic cancer
Wed, Jul 03, 2024 11:38 CET Report this content
Alligator Bioscience continues to post convincing phase II data with cancer immunotherapy mitazalimab in pancreatic c... |
| 02.07.2024 | BioStock: Spermosens - helping couples succeed in babymaking | BioStock: Spermosens - helping couples succeed in babymaking
Tue, Jul 02, 2024 09:07 CET Report this content
As infertility reaches an alarming rate, in vitro fertilisation is seen as a beacon of hope. Despite its successes, IVF too often l... |
| 01.07.2024 | BioStock: Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0” | BioStock: Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0”
Mon, Jul 01, 2024 08:15 CET Report this content
BioInvent recently announced promising clinical data for its lead cancer immunotherapy candidates, BI-1808 an... |
| 28.06.2024 | BioStock: Annexin comments on acquisition and focus on ANXV in ophthalmology | BioStock: Annexin comments on acquisition and focus on ANXV in ophthalmology
Fri, Jun 28, 2024 11:14 CET Report this content
Merck recently announced that they are acquiring the biotech company EyeBio for up to 3 billion USD, thereby streng... |
| 27.06.2024 | BioStock: Fast Track designation facilitates development of Oncoinvent’s Radspherin | BioStock: Fast Track designation facilitates development of Oncoinvent’s Radspherin
Thu, Jun 27, 2024 08:14 CET Report this content
The FDA has granted Fast Track to Oncoinvent for its radiopharmaceutical Radspherin as a treatment for perit... |
| 27.06.2024 | BioStock: Aqilion and Merck sever ties | BioStock: Aqilion and Merck sever ties
Thu, Jun 27, 2024 08:46 CET Report this content
Aqilion announced the termination of the licensing and collaboration agreement with Merck for the joint development of the TAK1 programme taking aim at c... |
| 27.06.2024 | BioStock: Medivir presents promising results in difficult-to-treat patient population | BioStock: Medivir presents promising results in difficult-to-treat patient population
Thu, Jun 27, 2024 10:00 CET Report this content
Medivir today presents new clinical data from its phase Ib/IIa study at ESMO GI in Munich. The company's c... |
| 26.06.2024 | BioStock: CombiGene positive to new license agreement for CG01 | BioStock: CombiGene positive to new license agreement for CG01
Wed, Jun 26, 2024 12:43 CET Report this content
CombiGene has entered into a new license agreement with Spark Therapeutics regarding intellectual property related to the epileps... |
| 25.06.2024 | BioStock: Curasight CEO comments on capital raise and milestone | BioStock: Curasight CEO comments on capital raise and milestone
Tue, Jun 25, 2024 09:15 CET Report this content
Curasight has enrolled the first patient in its phase II trial with uTRACE in prostate cancer, activating a second USD 500,000 p... |
| 25.06.2024 | BioStock: Prolight’s partner TTP provides update on MicroFlex development | BioStock: Prolight’s partner TTP provides update on MicroFlex development
Tue, Jun 25, 2024 10:52 CET Report this content
With the goal of delivering diagnostic tests closer to the patient, Prolight Diagnostics and TTP have developed the Po... |
| 20.06.2024 | Cereno Scientific releases BioStock interview with CEO Sten R. Sörensen regarding CS014 advancing to clinical Phase I | Cereno Scientific releases BioStock interview with CEO Sten R. Sörensen regarding CS014 advancing to clinical Phase I
Thu, Jun 20, 2024 07:50 CET Report this content
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech devel... |
| 20.06.2024 | BioStock: Lipum’s CEO comments on multiple-dose results in phase I | BioStock: Lipum’s CEO comments on multiple-dose results in phase I
Thu, Jun 20, 2024 08:45 CET Report this content
Following the positive single-dose results from the phase I study evaluating SOL-116, Lipum is now presenting additional prom... |
| 20.06.2024 | BioStock: Cereno's CEO – "CS014 adds potential for cardiovascular disease patients" | BioStock: Cereno's CEO – "CS014 adds potential for cardiovascular disease patients"
Thu, Jun 20, 2024 07:46 CET Report this content
Cereno Scientific is a biotech company developing treatments for the number one killer in the worl... |
| 19.06.2024 | BioStock: PHI grows its network of collaborations | BioStock: PHI grows its network of collaborations
Wed, Jun 19, 2024 08:42 CET Report this content
Phase Holographic Imaging has entered into a partnership with the University College London, the first partnership in a hospital setting to ex... |
| 19.06.2024 | Saniona’s CEO to BioStock: “We have meetings with potential partners every week” | Saniona’s CEO to BioStock: “We have meetings with potential partners every week”
Wed, Jun 19, 2024 09:55 CET Report this content
Saniona is currently advancing its epilepsy assets to provide clinical proof-of-concept for SAN711 and preparin... |
| 18.06.2024 | BioStock: BrainCool’s new CEO on his visions for the company | BioStock: BrainCool’s new CEO on his visions for the company
Tue, Jun 18, 2024 11:13 CET Report this content
BrainCool has strong momentum right now. Karolinska Institutet has initiated patient recruitment for a cardiac arrest study with th... |
| 17.06.2024 | BioStock: Chordate Medical enters agreement in Switzerland | BioStock: Chordate Medical enters agreement in Switzerland
Mon, Jun 17, 2024 08:58 CET Report this content
Chordate Medical adds Switzerland as a new focus market for the Ozilia migraine treatment entering into a new partnership agreement w... |
| 17.06.2024 | BioStock: Elicera teams up with China Medical University for cancer study | BioStock: Elicera teams up with China Medical University for cancer study
Mon, Jun 17, 2024 08:46 CET Report this content
Elicera Therapeutics has announced a new research collaboration with the Fourth Affiliated Hospital of China Medical U... |
| 14.06.2024 | BioStock: Rights issue takes Expres2ion breast cancer vaccine to phase I | BioStock: Rights issue takes Expres2ion breast cancer vaccine to phase I
Fri, Jun 14, 2024 08:45 CET Report this content
Having validated its vaccine platform in Covid-19, Expres2ion Biotech now turns to the treatment of breast cancer. A SE... |
| 13.06.2024 | BioStock: Brain+ CEO - “CST is becoming the standard in dementia care” | BioStock: Brain+ CEO - “CST is becoming the standard in dementia care”
Thu, Jun 13, 2024 08:46 CET Report this content
Brain+ is a health tech company focused on treatment and management of dementia. Centred around Cognitive Stimulation The... |
| 12.06.2024 | ExpreS2ion CEO to BioStock: “Compelling preclinical package gives us confidence” | ExpreS2ion CEO to BioStock: “Compelling preclinical package gives us confidence”
Wed, Jun 12, 2024 09:15 CET Report this content
Based on its proprietary protein expression platform, ExpreS2ion Biotech advances its ES2B-C001 breast cancer v... |
| 12.06.2024 | BioStock: BiBBInstruments’ technology gets nod in medical journal | BioStock: BiBBInstruments’ technology gets nod in medical journal
Wed, Jun 12, 2024 09:46 CET Report this content
The interest in Swedish medtech BiBBInstruments’ biopsy instrument EndoDrill is increasing as doctors evaluate it in the clini... |
| 11.06.2024 | BioStock Investor Pitch: Brain+ | BioStock Investor Pitch: Brain+
Tue, Jun 11, 2024 09:48 CET Report this content
Brain+ is a health tech company focused on treatment and management of dementia. Centred around the Cognitive Stimulation Therapy method, the company’s approach... |
| 11.06.2024 | BioStock: Biosergen towards first-in-patient trial with antifungal therapy | BioStock: Biosergen towards first-in-patient trial with antifungal therapy
Tue, Jun 11, 2024 08:45 CET Report this content
During Q1, Biosergen took major steps towards its goal to address the hidden threat of fungal infections. Not only wa... |
| 05.06.2024 | Neola’s CEO to BioStock: “The certificate is a clear sign of strength” | Neola’s CEO to BioStock: “The certificate is a clear sign of strength”
Wed, Jun 05, 2024 11:43 CET Report this content
Neola Medical’s product Neola, developed for continuously monitoring premature infants’ lungs, has been certified accordi... |
| 05.06.2024 | BioStock: CLS’ partner initiates full market release in the US | BioStock: CLS’ partner initiates full market release in the US
Wed, Jun 05, 2024 17:18 CET Report this content
CLS’ commercial partner ClearPoint Neuro has initiated its full market release of the ClearPoint Prism 3T Neuro Laser Therapy Sys... |
| 04.06.2024 | BioStock: Curasight committed to progressing pipeline | BioStock: Curasight committed to progressing pipeline
Tue, Jun 04, 2024 08:45 CET Report this content
The partnership with Curium for diagnosis in prostate cancer is advancing and Curasight aims to accelerate the development of the therapeu... |
| 04.06.2024 | BioStock: Alligator’s mitazalimab data published in The Lancet Oncology | BioStock: Alligator’s mitazalimab data published in The Lancet Oncology
Tue, Jun 04, 2024 09:15 CET Report this content
Alligator Bioscience’s phase II data with cancer immunotherapy mitazalimab have been published in The Lancet Oncology – ... |
| 03.06.2024 | Watch all videos from BioStock Global Forum 2024 | Watch all videos from BioStock Global Forum 2024
Mon, Jun 03, 2024 11:18 CET Report this content
On May 29-30, BioStock hosted the Global Forum. The event is the first of its kind, aimed at bringing together growth stage Nordic life science... |
| 31.05.2024 | BioStock: She is CombiGene’s new CSO | BioStock: She is CombiGene’s new CSO
Fri, May 31, 2024 10:43 CET Report this content
CombiGene’s former Director Preclinical Development Annika Ericsson has taken over the role of the company’s Chief Scientific Officer. BioStock contacted E... |
| 30.05.2024 | BioStock: BioInvent to present promising clinical data at ASCO and EHA | BioStock: BioInvent to present promising clinical data at ASCO and EHA
Thu, May 30, 2024 12:43 CET Report this content
In the coming weeks, BioInvent is set to present three significant data sets at the American Society for Clinical Oncolog... |
| 29.05.2024 | Ablivas CEO to BioStock: “We remain on track for the interim analysis early in Q3” | Ablivas CEO to BioStock: “We remain on track for the interim analysis early in Q3”
Wed, May 29, 2024 15:14 CET Report this content
During the first quarter of 2024, Abliva focused on progressing the FALCON clinical trial towards interim ana... |
| 29.05.2024 | BioStock: Elicera’s first clinical CAR T-Cell study CARMA set to begin | BioStock: Elicera’s first clinical CAR T-Cell study CARMA set to begin
Wed, May 29, 2024 10:04 CET Report this content
Elicera Therapeutics is on the brink of launching its first clinical CAR T-cell study, CARMA, which aims to generate cruc... |
| 28.05.2024 | BioStock: Prolight Diagnostics strengthens board with experienced business developer | BioStock: Prolight Diagnostics strengthens board with experienced business developer
Tue, May 28, 2024 08:15 CET Report this content
Prolight Diagnostics expands its Board of Directors with Kiarash Farr, who has extensive experience in sale... |
| 27.05.2024 | BioStock: Prolight Diagnostics CSO comments on latest data | BioStock: Prolight Diagnostics CSO comments on latest data
Mon, May 27, 2024 08:28 CET Report this content
Supported by the latest data from its Psyros point-of-care system, Prolight Diagnostics is ready to initiate pre-validation trials us... |
| 27.05.2024 | Hamlet BioPharma Participates in The Global Forum 2024 | Hamlet BioPharma Participates in The Global Forum 2024
Mon, May 27, 2024 13:30 CET Report this content
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participat... |
| 27.05.2024 | BioStock: AdjuTec advances toward phase I with regulatory green light | BioStock: AdjuTec advances toward phase I with regulatory green light
Mon, May 27, 2024 08:45 CET Report this content
Preparing to hit the clinical stage with its antibiotic resistance breakers, Norwegian AdjuTec Pharma recently got a goahe... |
| 27.05.2024 | Chordate Medical’s CEO to BioStock: “We are building step by step” | Chordate Medical’s CEO to BioStock: “We are building step by step”
Mon, May 27, 2024 10:12 CET Report this content
Chordate’s Q1 report shows higher sales and a reduced operating loss compared to the same period last year. The company has a... |
| 24.05.2024 | BioStock: CLS revises strategy – increases focus on neurosurgery | BioStock: CLS revises strategy – increases focus on neurosurgery
Fri, May 24, 2024 09:21 CET Report this content
Clinical Laserthermia Systems revises its strategy to increase the possibility of achieving the goal of reaching a positive cas... |
| 24.05.2024 | BioStock: Respiratorius takes another step toward partnering | BioStock: Respiratorius takes another step toward partnering
Fri, May 24, 2024 08:15 CET Report this content
The in-depth partner discussions have resulted in Respiratorius’ potential partner still being interested in co-financing a phase I... |
| 23.05.2024 | Flerie makes its way to the stock market via InDex | Flerie makes its way to the stock market via InDex
Thu, May 23, 2024 08:15 CET Report this content
The chess pieces have long been in place for Flerie Invest, and now the specialist investor will enter the stock market through reverse acqui... |
| 23.05.2024 | PHI to BioStock: “It’s the right moment to capitalize on regenerative medicine momentum.” | PHI to BioStock: “It’s the right moment to capitalize on regenerative medicine momentum.”
Thu, May 23, 2024 09:21 CET Report this content
Medtech company Phase Holographic Imaging recently secured a loan facility of SEK 7 million. The compa... |
| 22.05.2024 | BioStock: Full focus on financing and new CEO for Arcede | BioStock: Full focus on financing and new CEO for Arcede
Wed, May 22, 2024 08:15 CET Report this content
Preparations for phase I are largely complete. What Arcede Pharma now needs to solve is financing the upcoming study and getting a perm... |
| 22.05.2024 | BioStock: Interest in BiBBInstruments’ EndoDrill GI continues to increase | BioStock: Interest in BiBBInstruments’ EndoDrill GI continues to increase
Wed, May 22, 2024 08:46 CET Report this content
The world's first market-cleared electric-driven biopsy instrument for endoscopy, EndoDrill GI, continues its track re... |
| 21.05.2024 | BioStock: Iconovo initiates development of inhaled obesity treatment | BioStock: Iconovo initiates development of inhaled obesity treatment
Tue, May 21, 2024 08:15 CET Report this content
Iconovo has filed a broad patent application for inhaled GLP-1 receptor agonists, used for the treatment of obesity and typ... |
| 21.05.2024 | BioStock: Prolight Diagnostics’ CTO thrilled to receive UK government grant | BioStock: Prolight Diagnostics’ CTO thrilled to receive UK government grant
Tue, May 21, 2024 10:13 CET Report this content
Prolight Diagnostics has been awarded a SEK 17 million grant from National Institute for Health and Care Research’s ... |
